Recombinant antibody production in therapeutic antibody projects

Are you working on a Therapeutic Antibody project and considering the use of recombinant Antibodies (rAbs)? If yes, this webinar is for you. Monoclonal antibodies (mAbs) have emerged as the fastest growing class of therapeutics and there is a robust increase in the research and discovery of mAbs. While existing Ab discovery platforms are robust and effective, often times they need to be complemented with rAb production techniques. This webinar provides a big picture of rAb production technologies including high throughput (HTP) approaches for rAb production, within the context of therapeutic Ab projects. Case studies and GenScript rAb production services that match customer needs will also be discussed.

Recombinant antibody production in therapeutic antibody projects
  • 50 μg or 1 mg packages
  • Starting under $500
  • Rapid  turnaround - as little as 6 weeks
  • Ideal for Ab screening application, assays and HTP biophysical characterization studies
  • Gene synthesis included in package
  • Guaranteed rAb amount and purity
  • 5 mg-500 mg starting under $3000
  • Rapid turnaround – as little as 5 weeks
  • Ideal for in vitro applications
  • Gene synthesis included in package
  • Guaranteed rAb amount and purity
  • 500 mg-5000 mg
  • Rapid turnaround – as little as 9 weeks
  • Ideal for in vivo studies
Get Quote Get Quote Get Quote

Speaker-related Webinars